At a glance
- Originator Wyeth
- Class Antibacterials; Ethers
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gram-positive infections
Most Recent Events
- 20 Feb 1997 New profile
- 20 Feb 1997 Preclinical development for Gram-positive infections in USA (Unknown route)